The David Lehr Research Award honors outstanding research contributions in clinical pharmacology by established investigators, presented by the American Society for Pharmacology and Experimental Therapeutics.
Funder: American Society for Pharmacology and Experimental Therapeutics
Due Dates: September 21, 2026 (award deadline, 2027 cycle)
Funding Amounts: Honorific award; no stated monetary value or research support
Summary: Recognizes significant research contributions in clinical pharmacology by investigators aged 45 or older.
Key Information: Applicants must be at least 45 years old and active in clinical pharmacology.
This Scientific Achievement Award, presented by the American Society for Pharmacology and Experimental Therapeutics (ASPET), honors outstanding research contributions in the field of clinical pharmacology. The award is intended to recognize established investigators (aged 45 or older) who have made significant advancements in clinical pharmacology or closely related general pharmacology disciplines. The award aims to spotlight impactful research and celebrate continued excellence and innovation in the pharmacological sciences.